TD Cowen raised the firm’s price target on Cardinal Health (CAH) to $233 from $225 and keeps a Buy rating on the shares as part of a Q4 earnings preview. The firm views Cardinal’s fiscal Q2 result as “largely de-risked” given the guidance raise in mid January.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CAH:
- Wells says ‘Great Healthcare Plan’ lacks new onerous proposals
- Cardinal Health price target raised to $240 from $230 at BofA
- Cardinal Health price target raised to $250 from $232 at Baird
- Cardinal Health price target raised to $240 from $230 at Leerink
- Midday Fly By: JPMorgan reports mixed Q4, L3Harris to form new missile company